FDA approves new flu vaccine from GSK
submitted by kickingbird at Oct, 9, 2006 from Sun-Sentinel (via http://www.sun-sentinel.com/features/health/ny-bzflu1006,0,1)
The Food and Drug Administration has approved FluLaval, a new seasonal influenza vaccine from GlaxoSmithKline Plc.The FDA's approval of FluLaval Thursday boosts the country's expected flu vaccine supply ...
MedImmune Receives FDA Approval to Use Reverse Genetics Technology for FluMist(R) Vaccine Production
submitted by wanglh at Jul, 7, 2006 from PR News (via http://biz.yahoo.com/prnews/060706/nyth052a.html?.v=2)
MedImmune, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the company's supplemental biologics license application (sBLA) to use reverse genetics technology to construct ...
FDA warns Sanofi Pasteur after flu vaccine flunks test
submitted by wanglh at Jul, 5, 2006 from Pocono Record (via http://www.poconorecord.com/apps/pbcs.dll/article?AID=/20060)
The Food and Drug Administration has issued a warning letter to vaccine maker Sanofi Pasteur after Sanofi reported that some batches of its influenza vaccine failed sterility tests in April.That report ...
Mount Sinai School Of Medicine Licenses Avian Flu Vaccine To Avimex
submitted by wanglh at Jun, 28, 2006 from Medical News Today (via http://www.medicalnewstoday.com/medicalnews.php?newsid=45938)
Mount Sinai School of Medicine today announced that it has entered into a territory limited license agreement with Avimex* Animal Health. The privately owned world-leader in the avian influenza H5 emulsified ...
Glaxo aims to file bird flu vaccine in October
submitted by kickingbird at Jun, 23, 2006 from Reuters (via http://today.reuters.com/news/newsarticle.aspx?type=globalNe)
GlaxoSmithKline Plc plans to seek European approval in October for a new vaccine to prevent bird flu in humans, the head of its vaccines business said on Thursday.Europe's biggest drugmaker, which started ...
MedImmune And National Institutes Of Health Begin Clinical Testing Of A Live, Attenuated Intranasal Vaccine Against An H5N1 Avian Influenza Virus
submitted by kickingbird at Jun, 16, 2006 from Medical News Today (via http://www.medicalnewstoday.com/medicalnews.php?newsid=45286)
MedImmune, Inc.(Nasdaq: MEDI) announced today that the National Institutes of Health (NIH)has begun enrolling participants in a Phase 1 study of an intranasal H5N1influenza vaccine candidate based on the ...
China develops three new avian influenza vaccines
submitted by kickingbird at Jun, 14, 2006 from firstname.lastname@example.org (via http://news.xinhuanet.com/english/2006-06/14/content_4696992)
BEIJING, June 14 (Xinhua) -- China has just successfully developed three kinds of new avian ...
China-made Tamiflu approved for production
submitted by kickingbird at Jun, 13, 2006 from email@example.com (via http://news.xinhuanet.com/english/2006-06/13/content_4690379)
BEIJING, June 13 (Xinhua) -- A Chinese company has been approved by the State Food and Drug ...
New experimental flu vaccine bypasses needles
submitted by kickingbird at Jun, 2, 2006 from Reuters (via http://feeds.feedburner.com/Reuters/GlobalCoverage2?m=3722)
WASHINGTON (Reuters) - An experimental flu vaccine that blasts tiny particles into the skin instead of using a needle appears to be safe in people, biotech firm PowderMed Ltd. said on Wednesday. The British-based ...
Sanofi pasteur to License Micro-Delivery Technology From BD Medical [Primary member]
submitted by kickingbird at Dec, 21, 2005 from PRNewswire
Sanofi pasteur, thevaccines business of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY),has entered into an agreement with BD (Becton, Dickinson and Company)(NYSE: BDX) to license the Micro-Delivery ...
Contract Signed For The Development And Testing Of A Prototype Flu Pandemic Vaccine, Canada [Primary member]
submitted by kickingbird at Dec, 12, 2005 from Medical News today (via http://www.medicalnewstoday.com/medicalnews.php?newsid=34828)
Canada′s Health Minister Ujjal Dosanjh announced today that Canadian pharmaceutical manufacturer ID Biomedical has been contracted by the Government of Canada to produce and test a prototype vaccine to ...
Sinovac to Run Human Tests of Avian-Influenza Vaccine [Primary member]
submitted by kickingbird at Nov, 23, 2005 from bloomberg (via http://www.bloomberg.com/apps/news?pid=10000080&sid=a5sj)
Sinovac Biotech Ltd., a Beijing-based maker of human vaccines, plans to conduct human testing of a vaccine against avian influenza as the virus spreads across China´s poultry farms.
``We are in ...
Biota:FRENCH GOVERNMENT CONFIRMS RELENZA STOCKPILE OF 9 MILLION UNITS [Primary member]
submitted by kickingbird at Nov, 11, 2005 from Biota
Biota reported today that the French government has announced that it intends to increase its pandemic stockpile of Relenza from 200,000 units to 9 million units over the next two years .To read more on ...
QIAGEN Launches Advanced Diagnostic Tests for Detection of Influenza and Avian (Bird) Flu Virus [Primary member]
submitted by kickingbird at Oct, 8, 2005 from QIAGEN
QIAGEN Launches Advanced Diagnostic Tests for Detection of Influenza and Avian (Bird) Flu Virus
Company Expands Leading Molecular Diagnostics Portfolio With Human and Veterinary Applications
Quidel´s Flu Test Sensitivity Validated at 96% for Type A Influenza; Studies Provide Reassuring Data for Patients This Flu Season and Promising Data for Support of Avian Flu Surveillance [Primary member]
submitted by kickingbird at Oct, 22, 2005 from Genetic Engineering News (via http://www.genengnews.com/news/bnitem.aspx?name=1085149XSL_N)
Quidel Corporation (Nasdaq:QDEL), a leading provider of rapid point-of-care (POC) diagnostic tests, reported today that a clinical study to further validate the performance of its 10-minute diagnostic ...
Chiron Delivers FLUVIRIN(R) Influenza Virus Vaccine to U.S. Customers: First Shipments Mark Beginning of 2005-2006 FLUVIRIN Supply [Primary member]
submitted by kickingbird at Oct, 20, 2005 from Chiron Corporation
Oct. 17, 2005--Chiron Corporation (NASDAQ:CHIR) today announced that it has initiated the first delivery and release of FLUVIRIN(R) influenza virus vaccine to customers in the United States for the 2005-2006 ...
Wave Biotech Announces Strategic Alliance on Pandemic Influenza Vaccine Production Technologies [Primary member]
submitted by kickingbird at Oct, 18, 2005 from Wave Biotech, LLC
SOMERSET, N.J., Oct. 17 /PRNewswire/ -- Wave Biotech, LLC, has announcedtoday that the company is working with a number of worldwide pharmaceuticaland biotech manufacturers that are making vaccines in ...
Chiron Corporation´s FLUVIRIN(R) influenza virus vaccine [Primary member]
submitted by kickingbird at Oct, 18, 2005 from Genetic Engineering News (via http://www.genengnews.com/news/bnitem.aspx?name=1080896XSL_N)
Chiron Corporation (NASDAQ:CHIR) today announced that it has initiated the first delivery and release of FLUVIRIN(R) influenza virus vaccine to customers in the United States for the 2005-2006 influenza ...
GSK to buy Canada’s ID Biomedical for $1.4bn [Primary member]
submitted by kickingbird at Sep, 8, 2005 from Financial Times (via http://news.ft.com/cms/s/09299de8-1fb5-11da-853a-00000e2511c)
GlaxoSmithKline of the UK agreed to acquire ID Biomedical, the Canadian biotechnology company for $1.4bn, in a move that expands GSK’s access to flu vaccine production.
ID Biomedical, which has operations ...
GSK invests further in flu vaccine capacity [Primary member]
submitted by kickingbird at Sep, 6, 2005 from industry news
GlaxoSmithKline has acquired a manufacturing facility in the USA from Wyeth, and will invest at least $100 million (€80m) to develop and produce flu vaccines at the site using new tissue culture technology.GSK ...
144 items, 20/Page, Page[2/8][|<<] [|<]         [>|] [>>|]
Northen China: Beijing - Gansu -
Inner mongolia -
Southen China: Anhui -